Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Verstraeten

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|August 6, 2021
Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004-2015Elsa Negro Calduch, Tom Cattaert, Thomas Verstraeten
The Pediatric Infectious Disease Journal|November 15, 2017
Norovirus and Rotavirus Disease Severity in Children: Systematic Review and Meta-analysisMargarita Riera-Montes, Miguel O'Ryan, Thomas Verstraeten
Expert Review of Vaccines|November 25, 2016
Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility studyAnke L Stuurman, Thomas Verstraeten, Antoon De Schryver
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2020
Reply to Baird and DouglasMarc Bonten, Thomas Verstraeten, Stefan Gravenstein, et al.
Vaccine|January 8, 2016
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among childrenJorgen Stassijns, Kaatje Bollaerts, Marc Baay, et al.
Human Vaccines & Immunotherapeutics|April 26, 2017
Background rates of disease in Latin American children from a rotavirus vaccine studyMarc Baay, Kaatje Bollaerts, Claudio Struchiner, et al.
The Pediatric Infectious Disease Journal|January 7, 2006
Burden of rotavirus disease in European Union countriesMontse Soriano-Gabarró, Jacek Mrukowicz, Timo Vesikari, et al.
Acta Ophthalmologica|January 31, 2017
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular holeTimothy L Jackson, Thomas Verstraeten, Luc Duchateau, et al.
Expert Review of Vaccines|November 3, 2015
Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in malesLydie Marcelon, Thomas Verstraeten, Geraldine Dominiak-Felden, et al.
Investigative Ophthalmology & Visual Science|November 16, 2017
Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS StudyBenedicte Lescrauwaet, Luc Duchateau, Thomas Verstraeten, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|August 6, 2021
Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004-2015Elsa Negro Calduch, Tom Cattaert, Thomas Verstraeten
The Pediatric Infectious Disease Journal|November 15, 2017
Norovirus and Rotavirus Disease Severity in Children: Systematic Review and Meta-analysisMargarita Riera-Montes, Miguel O'Ryan, Thomas Verstraeten
Expert Review of Vaccines|November 25, 2016
Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility studyAnke L Stuurman, Thomas Verstraeten, Antoon De Schryver
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2020
Reply to Baird and DouglasMarc Bonten, Thomas Verstraeten, Stefan Gravenstein, et al.
Vaccine|January 8, 2016
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among childrenJorgen Stassijns, Kaatje Bollaerts, Marc Baay, et al.
Human Vaccines & Immunotherapeutics|April 26, 2017
Background rates of disease in Latin American children from a rotavirus vaccine studyMarc Baay, Kaatje Bollaerts, Claudio Struchiner, et al.
The Pediatric Infectious Disease Journal|January 7, 2006
Burden of rotavirus disease in European Union countriesMontse Soriano-Gabarró, Jacek Mrukowicz, Timo Vesikari, et al.
Acta Ophthalmologica|January 31, 2017
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular holeTimothy L Jackson, Thomas Verstraeten, Luc Duchateau, et al.
Expert Review of Vaccines|November 3, 2015
Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in malesLydie Marcelon, Thomas Verstraeten, Geraldine Dominiak-Felden, et al.
Investigative Ophthalmology & Visual Science|November 16, 2017
Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS StudyBenedicte Lescrauwaet, Luc Duchateau, Thomas Verstraeten, et al.
Pageof 8